STOCK TITAN

Oric Pharmaceuticals: T. Rowe Price reports 4.9%

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Oric Pharmaceuticals, Inc. (ORIC) was the subject of an ownership amendment in which T. Rowe Price Associates, Inc. reported beneficial ownership of 5,088,495 common shares, equal to 4.9% of the class. The amendment identifies September 30, 2026, as the event date. T. Rowe Price reported sole voting power over 5,079,985 shares and sole dispositive power over 5,088,495 shares, with no shared voting or dispositive power. It stated that the filing is not an admission of beneficial ownership and expressly denied being the beneficial owner.

Reported beneficial ownership 5,088,495 shares ORIC common stock; event date September 30, 2026
Ownership percentage 4.9% Of the class of ORIC common stock
Sole voting power 5,079,985 shares ORIC common stock
Sole dispositive power 5,088,495 shares ORIC common stock
beneficial ownership regulatory
"beneficial ownership is expressly denied"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
sole voting power regulatory
"Sole voting power 5,079,985.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
sole dispositive power regulatory
"Sole dispositive power 5,088,495.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ORIC shares did T. Rowe Price Associates report?

T. Rowe Price Associates, Inc. reported 5,088,495 ORIC common shares, equal to 4.9% of the class. It stated that the filing is not an admission of beneficial ownership and expressly denied being the beneficial owner.

What voting and disposition powers did T. Rowe Price report for ORIC shares?

T. Rowe Price Associates, Inc. reported sole voting power over 5,079,985 shares and sole dispositive power over 5,088,495 shares. It reported zero shared voting power and zero shared dispositive power.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





68622P109

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



T. Rowe Price Associates, Inc.
Signature:Ellen York
Name/Title:Vice President
Date:11/16/2026

Keep reading